Albumin and Furosemide Administration Protocol for Ascites Management
For patients requiring albumin infusion followed by furosemide, the proper dosing is to administer albumin 8 g/L of ascites removed for paracentesis >5 L, followed by oral furosemide starting at 40 mg daily (in combination with spironolactone 100 mg) for ongoing ascites management. 1, 2
Albumin Dosing Guidelines
- For large volume paracentesis (>5 L), administer 20% or 25% albumin solution at a dose of 8 g albumin/L of ascites removed after the procedure is completed 1
- For paracentesis <5 L, albumin (20% or 25% solution) can be considered at the same dose (8 g/L) in patients with acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury 1
- In spontaneous bacterial peritonitis (SBP), administer albumin 1.5 g/kg within 6 hours of diagnosis, followed by 1 g/kg on day 3, particularly in patients with increased serum creatinine or rising creatinine 1
- Albumin infusions should be completed before administering furosemide to maximize efficacy and minimize complications 3
Furosemide Dosing Guidelines
- For cirrhosis with ascites, start with oral furosemide 40 mg combined with spironolactone 100 mg as a single morning dose 2
- Doses can be increased simultaneously every 3-5 days if weight loss and natriuresis are inadequate, up to a maximum of 160 mg/day of furosemide and 400 mg/day of spironolactone 1, 2
- Oral administration is preferred in cirrhotic patients due to good bioavailability and to avoid acute reductions in glomerular filtration rate associated with IV administration 2
- If IV furosemide is necessary, administer slowly (1-2 minutes) to avoid ototoxicity 4
Sequential Administration Protocol
- Administer albumin and furosemide separately, using different infusion sites 3
- Complete the albumin infusion first, followed by furosemide administration 3
- Monitor electrolytes, kidney function, and hemodynamic parameters closely during treatment 3
Special Considerations
- Combination therapy with albumin and furosemide may enhance diuresis in patients with serum albumin levels <2.5 g/dL or in those with impaired renal function 5
- The diuretic effect of albumin-furosemide combination is most significant within the first 12 hours after administration 5
- Discontinue diuretics if severe hyponatremia, acute kidney injury, worsening hepatic encephalopathy, or incapacitating muscle cramps develop 3
- In patients with refractory ascites, consider transjugular intrahepatic portosystemic shunt (TIPSS) rather than escalating diuretic doses 1
Monitoring During Treatment
- Monitor for adverse events, as nearly half of patients require diuretic discontinuation or dose reduction 1
- Check electrolytes regularly, particularly sodium and potassium 2
- Assess kidney function through urine output and serum creatinine 2
- Evaluate fluid status through weight, blood pressure, and clinical examination 2
Common Pitfalls to Avoid
- Avoid simultaneous administration of albumin and furosemide in the same infusion, as this may reduce efficacy 3
- Do not administer furosemide in patients with marked hypovolemia, as it could worsen hypovolemia and promote thrombosis 2, 6
- Avoid high doses of furosemide (>6 mg/kg/day) for periods longer than 1 week due to risk of ototoxicity 6
- Do not use albumin in patients with cirrhosis and infections other than SBP, as it does not reduce the risk of acute kidney injury or mortality and may cause pulmonary edema 1